Cryo-Cell International AI Stock Analysis
Cryo-Cell International (ZCY) AI Stock Analysis
Cryo-Cell International
(Frankfurt:ZCY)
No summary available
Cryo-Cell International (ZCY) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 33.46M
- Dividend Yield
- ―
- Average Volume (3M)
- 831
- Price to Earnings (P/E)
- -18.5
- Beta (1Y)
- 0.25
- Revenue Growth
- -7.46%
- EPS Growth
- -252.40%
- Country
- Germany
- Employees
- 74
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Cryo-Cell International Business Overview & Revenue Model
Company Description
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical co...
Cryo-Cell International Risk Analysis
Cryo-Cell International disclosed 40 risk factors in its most recent earnings report. Cryo-Cell International reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
2 New RisksCryo-Cell International Peers Comparison
Overall Rating
SRTA58Neutral
CCM40Underperform
AIDX38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 58Neutral | $431.41M | -15.69 | -8.86% | ― | 22.73% | 3.40% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 40Underperform | $15.59M | -0.03 | 5.16% | ― | 20.26% | 69.68% | |
| 38Underperform | $2.53M | -0.22 | -315.65% | ― | ― | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:ZCY | Cryo-Cell International | 3.50 | 0.22 | 6.71% | |
| CCM | Concord Medical Services | 3.55 | -0.45 | -11.25% | |
| SRTA | Strata Critical Medical, Inc. | 4.56 | 0.30 | 7.04% | |
| NIVF | Newgenivf Group Limited | 0.03 | -5664.36 | -100.00% | |
| BMGL | Basel Medical Group Ltd | 0.38 | -13.42 | -97.22% | |
| AIDX | 20/20 Biolabs, Inc. | 0.16 | -23.69 | -99.34% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
